


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.61%
+0.08%
-8.89%
+0.11%
+0.02%
RARE
Ultragenyx Pharmaceu
$34.58
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Investors confidence is positive
RARE Price Performance
$33.76 (+2.43%)
$30.08 (+14.96%)
$28.46 (+21.50%)
$42.07 (-17.80%)
RARE has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

RARE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
RARE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RARE Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
What is RARE current stock price?
What are RARE stock strengths?
What is RARE Risk Level?
What is RARE market cap and volume?
What is RARE current Stock IQ?
Should I buy RARE stock right now?
Is RARE a Strong Buy right now?
What does a 'Strong Buy' rating mean for RARE?
What does a 'Strong Sell' rating mean for RARE?
What factors influence RARE's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.61%
+0.08%
-8.89%
+0.11%
+0.02%
RARE
Ultragenyx Pharmaceu
Current Price
$34.58
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Investors confidence is positive

RARE Price Performance
$33.76 (+2.43%)
$30.08 (+14.96%)
$28.46 (+21.50%)
$42.07 (-17.80%)
RARE Analysts Opinion
RARE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
RARE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RARE Street Sentiment is extremely bullish and have positive views on the near-term outlook
RARE has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
RARE Stock IQ
RARE Latest Analysis
Is Ultragenyx Pharmaceutical (RARE) One of the Best Biotech Stocks to Buy According to Wall Street Analysts?.
Thu Dec 11, 2025
Is Ultragenyx Pharmaceutical Inc. (RARE) One of the Best Biotech Stocks to Buy According to Wall Street Analysts?. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the best biotech stocks to buy according to Wall Street analysts. On December 4 Citi analyst Yigal Nochomovitz reiterated a Buy rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and set a $103 price target. The positive stance aligns with a Consensus Strong Buy rating from 13 Wall Street analysts [….]
Thu Dec 11, 2025
Wall Streets top picks for 2026: JPMorgan says a rare biopharma stock could more than triple. JPMorgan sees shares of Ultragenyx Pharmaceutical soaring more than 200% from current prices.
Fri Dec 5, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
RARE Stock trends
RARE Stock performance
RARE Stock analysis
RARE investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.